Attached files

file filename
8-K - FORM 8-K - LEXICON PHARMACEUTICALS, INC.form8-krightsoffering.htm
EX-99.5 - FORM OF BENEFICIAL OWNER ELECTION FORM - LEXICON PHARMACEUTICALS, INC.exh995formofbeneficialowne.htm
EX-5.1 - OPINION OF VINSON & ELKINS LLP - LEXICON PHARMACEUTICALS, INC.exh51opinionofvinsonelkins.htm
EX-4.1 - FORM OF SUBSCRIPTION RIGHTS CERTIFICATE AND ELECTION FORM - LEXICON PHARMACEUTICALS, INC.exh41formofsubscriptionrig.htm
EX-99.1 - FORM OF INSTRUCTIONS FOR USE OF SUBSCRIPTION RIGHTS CERTIFICATE AND ELECTION FORM - LEXICON PHARMACEUTICALS, INC.exh991formofinstructionsfo.htm
EX-99.3 - FORM OF LETTER TO NOMINEE HOLDERS - LEXICON PHARMACEUTICALS, INC.exh993formoflettertonomine.htm
EX-99.2 - FORM OF LETTER TO RECORD STOCKHOLDERS - LEXICON PHARMACEUTICALS, INC.exh992formoflettertorecord.htm
EX-99.4 - FORM OF LETTER TO CLIENTS OF NOMINEE HOLDERS - LEXICON PHARMACEUTICALS, INC.exh994formoflettertoclient.htm


Exhibit 99.6


NOMINEE HOLDER CERTIFICATION
LEXICON PHARMACEUTICALS, INC.
Up to 144,247,542 Shares of Common Stock Issuable Upon the Exercise of Subscription
Rights Distributed to the Record Shareholders of Lexicon Pharmaceuticals, Inc.
THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE
SET FORTH IN THE PROSPECTUS SUPPLEMENT OF LEXICON PHARMACEUTICALS, INC.
DATED NOVEMBER 22, 2011 AND THE ACCOMPANYING PROSPECTUS (THE “PROSPECTUS”).
The undersigned, a broker, securities dealer, custodian bank, trust company or other nominee holder (the “Nominee Holder') of non-transferable subscription rights (the “Subscription Rights”) to purchase shares of common stock, par value $0.001 (“Common Stock”), of Lexicon Pharmaceuticals, Inc. (the “Company”) pursuant to the subscription rights offering described and provided for in the Prospectus (the “Rights Offering”), hereby certifies to the Company and to BNY Mellon Shareowner Services, as subscription agent and information agent for the Rights Offering, that (1) the undersigned has exercised, on behalf of the beneficial owners thereof (which may include the undersigned), Subscription Rights to subscribe for and purchase the number of shares of Common Stock specified below pursuant to the Basic Subscription Privilege (as defined in the Prospectus) and Subscription Rights to purchase the number of shares of Common Stock specified below pursuant to the Over-Subscription Privilege (as defined in the Prospectus), listing separately below each such exercised Basic Subscription Privilege and the corresponding Over-Subscription Privilege (without identifying any such beneficial owner) and (2) to the extent a beneficial owner has elected to subscribe for shares pursuant to the Over-Subscription Privilege, each such beneficial owner's Basic Subscription Privilege has been exercised in full:
Number of Shares Owned
on Record Date
 
Number of Shares Subscribed
for Pursuant to Basic Subscription Privilege
 
Number of Shares Subscribed for Pursuant to Over-Subscription Privilege
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Print Name of the Nominee Holder:
 
 
 
By:
 
 
 
Print Signer's Name:
 
 
 
Contact Name:
 
 
 
Contact Phone Number:
 
 
 
Depository Trust company Participant Number of the Nominee Holder (if applicable):